Nodulation is reviewed when it comes to the phenotypes proposed by Vincent (1980). Particular person legumes could also be infectible by a number of of the three bacterial genera (collectively referred to as rhizobia) Rhizobium, Bradyrhizobium, or Azorhizobium. The kind of an infection course of by which rhizobia acquire entry is basically ruled by the host genotype. Along with the extensively studied root-hair pathway, infections could also be related to lateral root emergence or happen between root epidermal cells. The precise chemical and bodily nature of the foundation hair/epidermal cell wall is prone to be a essential consider figuring out whether or not infections can proceed.
Along with differing with species, wall composition could also be influenced by soil chemical (e.g. Ca2+ ) and biotic components (e.g. micro organism). Rhizobial options important for an infection embody explicit floor polysaccharides and the induction of nodulation genes by plant root exudates. Neither of those is prone to be a significant barrier to the extension of nodulation to new hosts. Dissemination of rhizobia inside creating nodules could also be intercellular, through an infection threads or by division of a small quantity of contaminated cells. All practical symbioses finally have ‘intracellular’ micro organism, within the sense that rhizobia are geographically situated inside the boundary of the host cell partitions.
Nevertheless, they continue to be extracellular within the sense that they’re at all times confined by a membrane which is basically of host cell origin. In some genera they’re additionally surrounded by an infection thread partitions, in all probability modified types of ‘invasive’ an infection thread partitions, which permit differentiation of rhizobia into the nitrogen-fixing type. Thus, pure, practical, symbioses might (a) by no means contain a stage through which micro organism are confined inside tubular an infection threads or (b) by no means launch micro organism from an infection threads. These options are decided by host genotype. The one characteristic of legume nodules thus far discovered by no means to fluctuate is the stem-like character of a peripheral vascular system.
This contrasts with the central vascular system of actinorhizas and the rhizobial-induced nodules on the Ulmaceous genus Parasponia. Though of nice intrinsic curiosity, this character is unlikely to current an insurmountable barrier to the extension of nodulation to new species. Different options, similar to the power to provide haemoglobin at the moment are identified to the within the genetic make-up of many larger vegetation. The invention of the big selection of nodule constructions occurring in nature, along with work on mutant rhizobia which can bypass essential levels within the nodulation course of, counsel varied methods through which the extension of nodulation to non-nodulated legumes and to different (initially no less than, dicotyledonous) vegetation could also be engineered.
Coronavirus consciousness, confinement stress, and psychological well being: Proof from Honduras, Chile, Costa Rica, Mexico and Spain
The commonest stress domains correspond to household (22.97%), monetary (22.53%), educational (16.47%), leisure time constraints (14.23%), well being (12.48%), peer group (7.63%), and non secular considerations (3.69%). These domains are considerably related to the respondent’s nation, intercourse, employment standing, and being or not a well being employee. Respondents who reported confinement stress additionally reported larger scores in anxiousness, despair, and somatization. The World Severity Index was considerably predicted by confinement stress, well being, educational, and leisure time-related stress, intercourse, age, being a well being employee, COVID-19 Private Concern, and Perceived Seriousness.
Non-significant predictors had been employment standing, the variety of folks at residence, presence of older adults and youngsters at residence, monetary, peer group, household, and non secular considerations; the regression mannequin had an R2 of 0.26. Comparable analyses had been carried out for somatization, despair, and anxiousness subscales. The COVID-19 pandemic has opposed results on the psychological well being of the final inhabitants, significantly relating to anxiousness, despair, and somatization. Particular populations, similar to ladies and healthcare employees, are at explicit danger of struggling a deterioration in psychological wellbeing. The implications of the examine for public coverage are mentioned.
Evaluation of human bioengineered cardiac tissue operate in hypoxic and re-oxygenized environments to grasp practical restoration in coronary heart failure
Myocardial restoration is likely one of the targets for coronary heart failure remedy. A non-negligible quantity of coronary heart failure with diminished ejection fraction (EF) sufferers expertise myocardial restoration by way of remedy. Though myocardial hypoxia has been reported to contribute to the development of coronary heart failure even in non-ischemic cardiomyopathy, the connection between contractile restoration and re-oxygenation and its underlying mechanisms stay unclear. The current examine investigated the results of hypoxia/re-oxygenation on bioengineered cardiac cell sheets-tissue operate and the underlying mechanisms.
Hypoxia (four days) elicited progressive decreases in contractile pressure, most contraction velocity, most leisure velocity, Ca2+ transient amplitude and ATP degree, however sarcomere construction and cell quantity weren’t affected. Re-oxygenation (eight days) after hypoxia (four days) was related to progressive will increase in contractile pressure, most contraction velocity and leisure time to the same extent ranges of steady normoxia group, whereas most leisure velocity was nonetheless considerably low even after re-oxygenation. Ca2+ transient magnitude, cell quantity, sarcomere construction and ATP degree after re-oxygenation had been just like these within the steady normoxia group.
 Recombinant Zea Mays Casein Kinase 2 alpha |
|
7-04233 |
CHI Scientific |
20µg |
Ask for price |
) Zea Mays Casein Kinase 2 alpha Protein (Recombinant) |
|
20-abx073023 |
Abbexa |
-
EUR 1345.20
-
EUR 2364.00
-
EUR 777.60
|
|
|
|
 Zea Mays Casein Kinase 2 alpha) Recombinant (E.Coli) Zea Mays Casein Kinase 2 alpha |
|
RP-668 |
Alpha Diagnostics |
3 ug |
EUR 708 |
 CK2a Casein Kinase 2 alpha Zea Mays Recombinant Protein |
|
PROTP28523 |
BosterBio |
Regular: 10ug |
EUR 1198.8 |
|
Description: Casein Kinase 2 alpha Zea Mays Recombinant is a non-glycosylated polypeptide having a molecular mass of 39.2 kDa. ;Casein Kinase 2 is purified by proprietary chromatographic techniques. |
 Recombinant other CK2a Zea Mays Protein, Untagged, E.coli-10ug |
|
QP11433-10ug |
EnQuireBio |
10ug |
EUR 1034.4 |
 Recombinant other CK2a Zea Mays Protein, Untagged, E.coli-20ug |
|
QP11433-20ug |
EnQuireBio |
20ug |
EUR 1873.2 |
 Recombinant other CK2a Zea Mays Protein, Untagged, E.coli-3ug |
|
QP11433-3ug |
EnQuireBio |
3ug |
EUR 555.6 |
 TesA, E. coli esterase |
|
0306-1 |
AthenaES |
100 Units |
EUR 505.2 |
 E. coli Topoisomerase IV |
|
TG2000EC-1 |
TopoGen |
250 units |
EUR 537.6 |
 E. coli DNA Gyrase |
|
TG2000G-1 |
TopoGen |
100 units |
EUR 388.8 |
 ) Streptavidin-Coated Strip Microwell Plate (Flat) |
|
R-1102 |
EpiGentek |
|
|
) Recombinant Nucleosome (E. coli-derived) |
|
52038-1 |
BPS Bioscience |
100 µg |
EUR 505 |
|
Description: Recombinant human nucleosome consisting of 147 bp DNA (PCR) and 2 molecules each of histones H2A, encompassing amino acids 2-130(end), H2B encompassing amino acids 2-126(end), H3 encompassing amino acids 2-137(end), and H4 encompassing amino acids 2-103(end). Each histone construct contains an N-terminal His-tag (6xHis). The recombinant complex was affinity purified. |
 Protein A) Recombinant purified >98% (E. Coli) Protein A |
|
PRTA11-R-1 |
Alpha Diagnostics |
1 mg |
EUR 169.2 |
 Pasteurella multocida outer membrane lipoprotein) Recombinant (E. coli) Pasteurella multocida outer membrane lipoprotein |
|
VacJ15-R-10 |
Alpha Diagnostics |
10 ug |
EUR 416.4 |
 E. coli RecA Protein |
|
01-001 |
Sceti |
200 ug |
EUR 246 |
|
Description: The E. coli RecA Protein is available in Europe and for worldwide shipping via Gentaur. |
 E. coli RuvA protein |
|
01-007 |
Sceti |
50 ug |
EUR 574.8 |
|
Description: The E. coli RuvA protein is available in Europe and for worldwide shipping via Gentaur. |
E. coli RuvA protein |
|
01-008 |
Sceti |
250 ug |
EUR 1420.8 |
|
Description: The E. coli RuvA protein is available in Europe and for worldwide shipping via Gentaur. |
 E. coli RuvB protein |
|
01-009 |
Sceti |
50 ug |
EUR 574.8 |
|
Description: The E. coli RuvB protein is available in Europe and for worldwide shipping via Gentaur. |
E. coli RuvB protein |
|
01-010 |
Sceti |
250 ug |
EUR 1420.8 |
|
Description: The E. coli RuvB protein is available in Europe and for worldwide shipping via Gentaur. |
 E. coli RuvC protein |
|
01-011 |
Sceti |
50 ug |
EUR 574.8 |
|
Description: The E. coli RuvC protein is available in Europe and for worldwide shipping via Gentaur. |
E. coli RuvC protein |
|
01-012 |
Sceti |
250 ug |
EUR 1420.8 |
|
Description: The E. coli RuvC protein is available in Europe and for worldwide shipping via Gentaur. |
 RecA Protein E. coli |
|
M1231-200 |
Biovision |
each |
EUR 242.4 |
 Protein) E. coli Syndecan 1 (SDC1) Protein |
|
20-abx263542 |
Abbexa |
-
EUR 994.80
-
EUR 493.20
-
EUR 644.40
|
|
|
|
 Outer membrane protein C Recombinant Protein (ompC/omp1b/porin, 22-367 aa, E. coli, >95%)) Recombinant (E. coli) Outer membrane protein C Recombinant Protein (ompC/omp1b/porin, 22-367 aa, E. coli, >95%) |
|
OMPC15-R-50 |
Alpha Diagnostics |
25 ug |
EUR 343.2 |
 Antibody) Escherichia coli (E. coli) Antibody |
|
abx415692-01mg |
Abbexa |
0.1 mg |
EUR 760.8 |
|
|
Escherichia coli (E. coli) Antibody |
|
abx415712-1ml |
Abbexa |
1 ml |
EUR 727.2 |
|
|
Escherichia coli (E. coli) Antibody |
|
abx411320-1ml |
Abbexa |
1 ml |
EUR 610.8 |
|
|
 E. Coli Recombinant Thioredoxin 1 |
|
6329-50 |
Biovision |
each |
EUR 483.6 |
 E. coli antibody |
|
10-E09C |
Fitzgerald |
100 ug |
EUR 159.6 |
|
Description: Mouse monoclonal E. coli antibody |
E. coli antibody |
|
10-E10A |
Fitzgerald |
500 ug |
EUR 591.6 |
|
Description: Mouse monoclonal E. coli antibody |
E. coli antibody |
|
10-E10B |
Fitzgerald |
500 ug |
EUR 591.6 |
|
Description: Mouse monoclonal E. coli antibody |
E. coli antibody |
|
20C-CR1244GP |
Fitzgerald |
1 ml |
EUR 561.6 |
|
Description: Goat polyclonal E. coli antibody |
E. coli antibody |
|
20-ER13 |
Fitzgerald |
1 ml |
EUR 426 |
|
Description: Rabbit polyclonal E. coli antibody |
E. coli antibody |
|
10C-CR1244M1 |
Fitzgerald |
100 ug |
EUR 489.6 |
|
Description: Mouse monoclonal E. coli antibody |
 E. coli Antibody |
|
abx021669-1mg |
Abbexa |
1 mg |
EUR 1554 |
|
|
E. coli Antibody |
|
abx021670-1mg |
Abbexa |
1 mg |
EUR 1045.2 |
|
|
E. coli Antibody |
|
abx021671-02ml |
Abbexa |
0.2 ml |
EUR 594 |
|
|
E. coli Antibody |
|
abx021672-1mg |
Abbexa |
1 mg |
EUR 1045.2 |
|
|
E. coli Antibody |
|
abx021673-1mg |
Abbexa |
1 mg |
EUR 1045.2 |
|
|
E. coli Antibody |
|
abx022970-1ml |
Abbexa |
1 ml |
EUR 878.4 |
|
|
E. coli Antibody |
|
abx022971-1ml |
Abbexa |
1 ml |
EUR 1161.6 |
|
|
E. coli Antibody |
|
abx022975-1ml |
Abbexa |
1 ml |
EUR 718.8 |
|
|
E. coli Antibody |
|
abx022977-1ml |
Abbexa |
1 ml |
EUR 811.2 |
|
|
 from E. coli (strain K-235) purified) Lipopolysaccharides (LPS) from E. coli (strain K-235) purified |
|
LPS12-1 |
Alpha Diagnostics |
1 mg |
EUR 270 |
 from E. coli (strain 0157:H7) purified) Lipopolysaccharides (LPS) from E. coli (strain 0157:H7) purified |
|
LPS15-1 |
Alpha Diagnostics |
1 mg |
EUR 270 |
) E. coli Topo IV Drug Screening Kit (20ug kDNA) |
|
TG1008-1 |
TopoGen |
100 assays |
EUR 388.8 |
, Isoform A, His-Tag (E. coli-derived)) KRAS (G12R), Isoform A, His-Tag (E. coli-derived) |
|
100841-1 |
BPS Bioscience |
100 µg |
EUR 320 |
|
Description: Human KRAS also known as C-K-RAS, CFC2, and K-RAS2A, GenBank Accession No. NM_033360, a.a. 2-186, with G12R mutation and N-terminal His-tag, expressed in an E. coli expression system. MW=23 kDa. |
 Apical membrane antigen 1 mosaic protein (>95%, His-tag protein, P.falciparum)) Recombinant (E. coli) Apical membrane antigen 1 mosaic protein (>95%, His-tag protein, P.falciparum) |
|
AMA15-R-10 |
Alpha Diagnostics |
10 ug |
EUR 416.4 |
 Protein) E. coli O157 Verotoxin 1 (VT1) Protein |
|
abx061526-100ug |
Abbexa |
100 ug |
EUR 1212 |
|
|
) Recombinant HSV-1 gD Protein (E. coli) |
|
VAng-0550Lsx-inquire |
Creative Biolabs |
inquire |
Ask for price |
|
Description: The E. coli derived recombinant protein contains the HSV-1 gD immunodominant regions. MW 40.6 kDa, 1.00 mg/mL. |
 Antibody (Biotin)) Escherichia coli (E. coli) Antibody (Biotin) |
|
abx415713-1ml |
Abbexa |
1 ml |
EUR 861.6 |
|
|
Escherichia coli (E. coli) Antibody (Biotin) |
|
abx411321-1ml |
Abbexa |
1 ml |
EUR 710.4 |
|
|
 Antibody (FITC)) Escherichia coli (E. coli) Antibody (FITC) |
|
abx411322-1ml |
Abbexa |
1 ml |
EUR 610.8 |
|
|
 E. Coli O 157 Protein |
|
abx061475-01ml |
Abbexa |
0.1 ml |
EUR 661.2 |
|
|
) Escherichia coli Outer membrane protein C (ompC) |
|
1-CSB-EP356994ENV |
Cusabio |
-
EUR 733.20
-
EUR 370.80
-
EUR 2192.40
-
EUR 1126.80
-
EUR 1461.60
-
EUR 476.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
|
|
Description: Recombinant Escherichia coli Outer membrane protein C(ompC) expressed in E.coli |
Escherichia coli Outer membrane protein C (ompC) |
|
1-CSB-EP356994ENVa0 |
Cusabio |
-
EUR 733.20
-
EUR 370.80
-
EUR 2192.40
-
EUR 1126.80
-
EUR 1461.60
-
EUR 476.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
|
|
Description: Recombinant Escherichia coli Outer membrane protein C (ompC) expressed in E.coli |
Escherichia coli Outer membrane protein C (ompC) |
|
1-CSB-EP356994ENVe1 |
Cusabio |
-
EUR 872.40
-
EUR 510.00
-
EUR 2331.60
-
EUR 1266.00
-
EUR 1602.00
-
EUR 615.60
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
|
|
Description: Recombinant Escherichia coli Outer membrane protein C(ompC) expressed in E.coli |
) Escherichia coli Outer membrane protein F (ompF) |
|
1-CSB-EP365808ENV |
Cusabio |
-
EUR 733.20
-
EUR 370.80
-
EUR 2192.40
-
EUR 1126.80
-
EUR 1461.60
-
EUR 476.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
|
|
Description: Recombinant Escherichia coli Outer membrane protein F(ompF) expressed in E.coli |
) ZYCY10P3S2T E. coli Minicircle producer strain (competent, ready to transform) |
|
MN900A-1 |
SBI |
5 vials |
EUR 733.2 |
|
|
 from E. coli (strain O26:B6) gel purified) Lipopolysaccharides (LPS) from E. coli (strain O26:B6) gel purified |
|
LPS16-1 |
Alpha Diagnostics |
1 mg |
EUR 270 |
 from E. coli (strain O55:B5) gel purified) Lipopolysaccharides (LPS) from E. coli (strain O55:B5) gel purified |
|
LPS17-1 |
Alpha Diagnostics |
1 mg |
EUR 270 |
) E. coli Topoisomerase IV Drug Screening Kit (25ug SC DNA) |
|
TG1007-1 |
TopoGen |
100 assays |
EUR 388.8 |
) Escherichia coli Outer membrane protein A (ompA) |
|
1-CSB-CF364256ENV(A4) |
Cusabio |
-
EUR 1560.00
-
EUR 688.80
-
EUR 996.00
|
|
|
|
|
Description: Recombinant Escherichia coli Outer membrane protein A(ompA) expressed in in vitro E.coli expression system |
 E. coli STX 1 & 2 Antibody |
|
abx021692-1mg |
Abbexa |
1 mg |
EUR 1612.8 |
|
|
) TGF-?1, human recombinant (E. Coli) |
|
7843-10 |
Biovision |
each |
EUR 418.8 |
TGF-?1, human recombinant (E. Coli) |
|
7843-1000 |
Biovision |
each |
EUR 4822.8 |
TGF-?1, human recombinant (E. Coli) |
|
7843-50 |
Biovision |
each |
EUR 966 |
) E. coli antibody (FITC) |
|
60-E13 |
Fitzgerald |
1 ml |
EUR 453.6 |
|
Description: Rabbit polyclonal E. coli antibody (FITC) conjugated |
) E. coli antibody (biotin) |
|
60-E13B |
Fitzgerald |
1 ml |
EUR 561.6 |
|
Description: Rabbit polyclonal E. coli antibody (biotin) conjugated |
) E. coli antibody (HRP) |
|
60-E14 |
Fitzgerald |
1 ml |
EUR 489.6 |
|
Description: Rabbit polyclonal E. coli antibody (HRP) conjugated |
 E. coli O157 antibody |
|
10-1490 |
Fitzgerald |
100 ug |
EUR 163.2 |
|
Description: Mouse monoclonal E. coli O157 antibody |
E. coli O157 antibody |
|
10-1521 |
Fitzgerald |
100 ug |
EUR 170.4 |
|
Description: Mouse monoclonal E. coli O157 antibody |
E. coli O157 antibody |
|
10-E12A |
Fitzgerald |
100 ug |
EUR 462 |
|
Description: Mouse monoclonal E. coli O157 antibody |
 E. coli DnaJ Antibody |
|
32022-05111 |
AssayPro |
150 ug |
EUR 313.2 |
 E. coli pykF Antibody |
|
32163-05111 |
AssayPro |
150 ug |
EUR 313.2 |
 E. coli GOR Antibody |
|
32540-05111 |
AssayPro |
150 ug |
EUR 313.2 |
 E. coli CysH Antibody |
|
30281-05111 |
AssayPro |
150 ug |
EUR 313.2 |
 E. Coli HCP antibody |
|
20R-EG001 |
Fitzgerald |
1 ml |
EUR 1004.4 |
|
Description: Goat polyclonal E. Coli HCP antibody |
 E. coli NDK Antibody |
|
32662-05111 |
AssayPro |
150 ug |
EUR 313.2 |
 E. coli PPA Antibody |
|
32678-05111 |
AssayPro |
150 ug |
EUR 313.2 |
 E. coli glk Antibody |
|
32864-05111 |
AssayPro |
150 ug |
EUR 313.2 |
 E. Coli ldhA Antibody |
|
32898-05111 |
AssayPro |
150 ug |
EUR 313.2 |
 E. coli deoC Antibody |
|
32936-05111 |
AssayPro |
150 ug |
EUR 313.2 |
 E. coli Skp Antibody |
|
32971-05111 |
AssayPro |
150 ug |
EUR 313.2 |
 E. coli nanA Antibody |
|
33092-05111 |
AssayPro |
150 ug |
EUR 313.2 |
E. coli O157 antibody |
|
10C-CR1295M3 |
Fitzgerald |
100 ug |
EUR 470.4 |
|
Description: Mouse monoclonal E. coli O157 antibody |
 E. coli LexA repressor |
|
01-005 |
Sceti |
50 ug |
EUR 574.8 |
|
Description: The E. coli LexA repressor is available in Europe and for worldwide shipping via Gentaur. |
E. coli LexA repressor |
|
01-006 |
Sceti |
250 ug |
EUR 1420.8 |
|
Description: The E. coli LexA repressor is available in Europe and for worldwide shipping via Gentaur. |
TesA, E. coli esterase |
|
0306-5 |
AthenaES |
500 Units |
EUR 2046 |
 E. coli GroEL Antibody |
|
20012-05011 |
AssayPro |
150 ug |
EUR 260.4 |
 E. coli O157 Antibody |
|
abx021684-1mg |
Abbexa |
1 mg |
EUR 1220.4 |
|
|
E. coli O157 Antibody |
|
abx021685-1mg |
Abbexa |
1 mg |
EUR 1195.2 |
|
|
E. coli O157 Antibody |
|
abx021686-1mg |
Abbexa |
1 mg |
EUR 1195.2 |
|
|
E. coli O157 Antibody |
|
abx021687-1mg |
Abbexa |
1 mg |
EUR 1195.2 |
|
|
E. coli O157 Antibody |
|
abx021688-1mg |
Abbexa |
1 mg |
EUR 1128 |
|
|
E. coli O157 Antibody |
|
abx021689-1mg |
Abbexa |
1 mg |
EUR 1195.2 |
|
|
) E. coli Antibody (HRP) |
|
abx022972-1ml |
Abbexa |
1 ml |
EUR 718.8 |
|
|
) E. coli Antibody (FITC) |
|
abx022974-1ml |
Abbexa |
1 ml |
EUR 777.6 |
|
|
) E. coli Antibody (Biotin) |
|
abx022976-1ml |
Abbexa |
1 ml |
EUR 718.8 |
|
|
E. coli Antibody (HRP) |
|
abx022978-1ml |
Abbexa |
1 ml |
EUR 1053.6 |
|
|
E. coli Antibody (Biotin) |
|
abx022979-1ml |
Abbexa |
1 ml |
EUR 886.8 |
|
|
E. coli O157 Antibody |
|
abx024017-1mg |
Abbexa |
1 mg |
EUR 1212 |
|
|
 E. coli O 157 |
|
abx291002-100mg |
Abbexa |
100 mg |
EUR 744 |
|
|
) Enterotoxin STp (E. coli) |
|
H-6248.0500 |
Bachem |
0.5mg |
EUR 835.2 |
|
Description: Sum Formula: C81H110N20O26S6; CAS# [115474-04-9] net |
Enterotoxin STp (E. coli) |
|
H-6248.1000 |
Bachem |
1.0mg |
EUR 1416 |
|
Description: Sum Formula: C81H110N20O26S6; CAS# [115474-04-9] net |
E. coli Topoisomerase IV |
|
TG2000EC-3 |
TopoGen |
500 units |
EUR 819.6 |
E. coli Topoisomerase IV |
|
TG2000EC-5 |
TopoGen |
1000 units |
EUR 1262.4 |
E. coli DNA Gyrase |
|
TG2000G-3 |
TopoGen |
500 units |
EUR 846 |
E. coli DNA Gyrase |
|
TG2000G-5 |
TopoGen |
1000 units |
EUR 1396.8 |
E. coli DNA Gyrase |
|
TG2000G-7 |
TopoGen |
2000 units |
EUR 2203.2 |
 E. coli DNA Ligase |
|
M1217-100 |
Biovision |
each |
EUR 385.2 |
 E. coli Exonuclease I |
|
M1222-100 |
Biovision |
each |
EUR 301.2 |
 E. coli Exonuclease III |
|
M1223-100 |
Biovision |
each |
EUR 320.4 |
 E. coli Recombinant IDNK |
|
P1050-10 |
Biovision |
each |
EUR 196.8 |
E. coli Recombinant IDNK |
|
P1050-50 |
Biovision |
each |
EUR 457.2 |
 Recombinant E. coli, Glucokinase |
|
P1054-10 |
Biovision |
each |
EUR 196.8 |
Recombinant E. coli, Glucokinase |
|
P1054-50 |
Biovision |
each |
EUR 457.2 |
 Benzonase, E. Coli Recombinant |
|
7680-25 |
Biovision |
each |
EUR 398.4 |
Benzonase, E. Coli Recombinant |
|
7680-5 |
Biovision |
each |
EUR 164.4 |
 E. Coli Recombinant TRXB |
|
6331-100 |
Biovision |
each |
EUR 510 |
 E. Coli Recombinant SlyD |
|
6366-100 |
Biovision |
each |
EUR 548.4 |
E. coli O157 Antibody |
|
V3307-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: This mAb shows specificity to E. coli O157 in a simple ELISA. Escherichia coli are Gram negative bacterium that are commonly found in the lower intestine of warm-blooded organisms (endotherms). Their serological types are determined in combination with somatic antigens (O group: O1-O173) and flagella antigens (H type: H1-H56). The E. coli that cause intestinal infectious diseases including diarrhea, acute gastritis or colitis are referred to as pathogenic E. coli, which are classified into the following four groups according to differences in the mode of pathogenicity; enteropathogenic E. coli (EPEC), enteroinvasive E. coli (EIEC), enterotoxigenic E. coli (ETEC) and enterohemorrhagic E. coli (EHEC). Although the identification of pathogenic E. coli requires verification of their pathogenicity, pathogenic E. coli often have specific serotypes; therefore, typing of the serogroup and serotype is necessary in screening pathogenic E. coli. |
E. coli O157 Antibody |
|
V3307-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: This mAb shows specificity to E. coli O157 in a simple ELISA. Escherichia coli are Gram negative bacterium that are commonly found in the lower intestine of warm-blooded organisms (endotherms). Their serological types are determined in combination with somatic antigens (O group: O1-O173) and flagella antigens (H type: H1-H56). The E. coli that cause intestinal infectious diseases including diarrhea, acute gastritis or colitis are referred to as pathogenic E. coli, which are classified into the following four groups according to differences in the mode of pathogenicity; enteropathogenic E. coli (EPEC), enteroinvasive E. coli (EIEC), enterotoxigenic E. coli (ETEC) and enterohemorrhagic E. coli (EHEC). Although the identification of pathogenic E. coli requires verification of their pathogenicity, pathogenic E. coli often have specific serotypes; therefore, typing of the serogroup and serotype is necessary in screening pathogenic E. coli. |
E. coli O157 Antibody |
|
V3307SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: This mAb shows specificity to E. coli O157 in a simple ELISA. Escherichia coli are Gram negative bacterium that are commonly found in the lower intestine of warm-blooded organisms (endotherms). Their serological types are determined in combination with somatic antigens (O group: O1-O173) and flagella antigens (H type: H1-H56). The E. coli that cause intestinal infectious diseases including diarrhea, acute gastritis or colitis are referred to as pathogenic E. coli, which are classified into the following four groups according to differences in the mode of pathogenicity; enteropathogenic E. coli (EPEC), enteroinvasive E. coli (EIEC), enterotoxigenic E. coli (ETEC) and enterohemorrhagic E. coli (EHEC). Although the identification of pathogenic E. coli requires verification of their pathogenicity, pathogenic E. coli often have specific serotypes; therefore, typing of the serogroup and serotype is necessary in screening pathogenic E. coli. |
Hypoxia/re-oxygenation up-regulated mRNA expression of PLN. Hypoxia and re-oxygenation situation instantly affected human bioengineered cardiac tissue operate. Additional understanding the molecular mechanisms of practical restoration of cardiac tissue after re-oxygenation would possibly present us the brand new perception on coronary heart failure with recovered ejection fraction and preserved ejection fraction.
